Andrew Rosindell

Andrew Rosindell

Reform UK — Romford

Speaking in the House of Commons on 6 February 2025

Debate

Business of the House

Contribution

I would like the Leader of the House to know that a number of my constituents have contacted me regarding the prescribing of antidepressant medicine in the UK and the iatrogenic harm caused to patients by antidepressant medication. Many are now diagnosed and suffering from conditions including post-acute withdrawal syndrome and post-SSRI—selective serotonin reuptake inhibitors—dysfunction. My right hon. Friend the Member for Tatton (Esther McVey) held a Westminster Hall debate on this issue only last year. However, given the severity of the concerns raised, will the Leader of the House consider a full debate in Government time on this very important matter?

More from Andrew Rosindell

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Andrew Rosindell's full parliamentary record including voting history, expenses and all other contributions, see the Andrew Rosindell report card.